- Cation-tuned stimuli-responsive and optical properties of supramolecular hydrogels
-
Hierarchical self-assembly of an amphiphilic tris-urea in aqueous media is shown. A mixture of the amphiphilic tris-urea and an alkaline solution gave a viscous solution composed of fibrous aggregates. This viscous solution transformed into supramolecular
- Yamanaka, Masamichi,Yanai, Kazushige,Zama, Yusuke,Tsuchiyagaito, Junko,Yoshida, Masaru,Ishii, Ayumi,Hasegawa, Miki
-
-
Read Online
- MODIFIED BIOTIN, STREPTAVIDIN MUTANT, AND USAGE OF THEM
-
An object of this invention is to provide a streptavidin mutant reduced in affinity to the naturally-occurring biotin, and to provide a modified biotin which shows a high affinity to such streptavidin mutant reduced in affinity to the naturally-occurring biotin. This invention can provide a compound composed of a dimer of modified biotin, a streptavidin mutant, angsd usage of them.
- -
-
Paragraph 0113; 0114
(2021/01/08)
-
- Histone lysine methyltransferase NSD2 inhibiting small-molecule compound and application thereof
-
The invention belongs to the field of chemical medicine and particularly relates to a histone lysine methyltransferase NSD2 inhibiting small-molecule compound. A general formula of the small-moleculecompound is as shown in the specification. According to
- -
-
Paragraph 0276-0282
(2019/05/22)
-
- COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.
- -
-
Page/Page column 115
(2010/06/19)
-
- COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and in the claims. The invention also relates to the use thereof for treat
- -
-
Page/Page column 67
(2010/07/08)
-
- INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
The invention relates to the substituted 1,2-ethylenediamines of general formula (I), wherein the groups R1 to R13, A, B, L and i are defined as in the description and the claims. The invention also relates to the use thereof in the
- -
-
Page/Page column 48
(2010/12/29)
-